experimental
Term · Oncology and biomedicine · MLC-T-ONC-003062
In clinical trials, refers to a drug (including a new drug, dose, combination, or route of administration) or procedure that has undergone basic laboratory testing and received approval from the U.S. Food and Drug Administration (FDA) to be tested in human subjects. A drug or procedure may be approved by the FDA for use in one disease or condition, but be considered experimental in other diseases or conditions. Also called investigational.
| Identifier | MLC-T-ONC-003062 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | investigational |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003062",
"term": "experimental",
"field": "Oncology and biomedicine",
"definition": "In clinical trials, refers to a drug (including a new drug, dose, combination, or route of administration) or procedure that has undergone basic laboratory testing and received approval from the U.S. Food and Drug Administration (FDA) to be tested in human subjects. A drug or procedure may be approved by the FDA for use in one disease or condition, but be considered experimental in other diseases or conditions. Also called investigational.",
"synonyms": [
"investigational"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/experimental/"
}
Record 7,040 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.